Emcure Pharma To Launch Oral COVID-19 Drug

[email protected]10 Jan, 2022News

Emcure Pharmaceuticals Limited (EPL) has received an Emergency Use Authorisation (EUA) approval from the Drug Controller General of India for the launch of Molnupiravir, an investigational oral anti-viral drug, for the treatment of mild COVID-19. EPL plans to launch Molnupiravir under the brand name Lizuvira in the Indian market. EPL will endeavour to deliver Lizuvira (Molnupiravir) in a week. A toll-free Helpline will be dedicated to helping the doctors and patients access the product.